NEW YORK, Nov. 18 (GenomeWeb News) - When it opens its doors in July 2006, the Louis V. Gerstner, Jr. School of Biomedical Sciences at the Memorial Sloan-Kettering Cancer Center will try to bring together basic cancer research, including genomics and various cell-signaling disciplines, with clinical practice, said Thomas Kelly, director of the Sloan-Kettering Institute and provost of the new graduate school in a statement today.
The school hopes to offer a curriculum including a one-year course covering "all aspects" of cancer biology, according to the statement.
Named after Louis Gerstner, a board of overseers vice president, philanthropic donor, and president of the board of trustees, the school will be housed in a new research building with "open floor labs" dedicated to chemical biology, immunology, human oncology and pathogenesis, and molecular pharmacology.
When the school opens, it will enroll 10-12 students leading to a PhD in cancer biology, said the statement, eventually leading to a total enrollment of 60.